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At a global level, with the increase in healthcare costs, there is a need to assess the
economic impact of the incorporation of new technologies in different health disorders
in different countries. There is scarce information regarding costs incurred with the
use of current or new diagnostic tests for tuberculosis or from the vantage point of
their incorporation within the healthcare systems of high-burden countries. The present
study aimed to assess the mean cost and the activity based cost of the laboratory
diagnosis for tuberculosis by means of conventional techniques and from the Detect
TB R©LabTest molecular test kit in a general high-complexity hospital of the public health
system in Brazil. Cost analysis was performed by means of primary data, collected
in the Mycobacteria and Molecular Biology Laboratory in 2013. The mean cost and
activity based cost were, respectively, U$10.06/U$5.61 for centrifuged bacilloscopy
by Ziehl Neelsen (ZN) and Auramine (AU); U$7.42/U$4.15 for direct bacilloscopy
by ZN; U$27.38/U$16.50 for culture in a Loweinstein-Jensen solid medium; and
U$115.74/U$73.46 for the Detect TB R©LabTest Kit. The calculation of the ABC should
be used in making decisions by administrators to be the best method of assessing
the costs of conventional techniques and molecular method for providing the real value
of the tests. So it is need to calculate the ABC, and not of the mean cost, in various
scenarios before incorporating new technologies in health institutions.
Keywords: tuberculosis, health system, cost analysis, mycobacteria, technology
INTRODUCTION
Tuberculosis (TB) remains as one of the central problems of world public health. In 2015, in Brazil,
some 71,221 new cases were notified, with 73% confirmed by laboratory diagnosis (bacilloscopy
or culture), and 71% presented treatment success (WHO, 2016). The diagnosis of TB by means of
high-quality mycobacteriological exams associated with clinical/epidemiological and radiological
criteria represent efficient strategies to TB control (BRASIL, 2010). However, these conventional
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methods present some disadvantages, such as low sensitivity and
specificity, as in the case of the bacilloscopy and chest X-ray (The
International Journal of Tuberculosis, and Lung Disease [IJTLD],
2012).
The culture, considered the “gold standard”, has limitations,
which are inherently linked to the time needed to obtain the
results and the need for a robust infrastructure in the laboratory,
which is limited to reference centers (Gholoobi et al., 2014).
Molecular diagnosis is reported to have higher sensitivity than
bacilloscopy and faster than cultures (Almeida et al., 2015). As of
2008, the World Health Organization (WHO) endorsed the use
of molecular methods to detect TB and drug-resistant TB as an
alternative to a faster diagnosis of TB (WHO, 2008).
These methods present a high specificity, though lower
sensitivity in patients with negative bacilloscopy results. The
most commercial molecular methods used to detect TB and
drug-resistant TB are the GenoType R©MTBDRplus (Biomeuriéx)
and the Xpert MTB/RIF R© (Cepheid). One major advantage of
these methods is that these can provide results more quickly
than the culture, yet the greatest disadvantage is that they are
too expensive and too complex for routine use in contexts
with limited resources (Steingart et al., 2015). In Brazil, the
Xpert MTB/RIF R© was introduced into the public system by
recommendation from the Ministry of Health in 2014. A new
kit developed in Brazil (Detect TB R©LabTestKit, MG, Brazil) has
been used for the molecular diagnoses of the Mycobacterium
tuberculosis Complex (MTBC) (BRASIL, 2011; Michelon et al.,
2011; Schimd et al., 2014).
Nevertheless, in high-burden countries, data concerning the
costs incurred with the use of diagnostic tests for TB are scarce
in routine conditions, and the TB control programs require
decision-making based on algorithms of diagnoses that consider
the laboratory costs, as well as those related to clinical treatment
and the local prevalence of TB (Shah et al., 2013). At the global
level, with the increase in healthcare costs, there is a growing need
to assess TB diagnostic methods, both current methods and those
planned for future implementation in different countries (Silva,
2003; BRASIL, 2011).
While there are large numbers of studies on accuracy of TB
diagnostic tests, there are few studies that are focused on cost.
Study conducted in Thailand demonstrated that the costs by Ziehl
Neelsen (ZN) and Auramine (AU) were very close. In Zambia
compared the values of the culture by different techniques in
liquid and solid media found few variations. In South Africa,
the cost of molecular method (Xpert MTB/RIF R©) was similar to
conventional automated liquid culture-based methods and the
GenoType R©MTBDRplus was higher (Mueller et al., 2008; Sohn
et al., 2009a,b; Shah et al., 2013).
Within the methodologies used to calculate the costs of
health services, activity based costing (ABC) is appropriate for
complex organizations, in which the products consume resources
in a highly heterogeneous manner, such as occurs in hospitals.
The benefits of ABC are many, especially because it improves
managerial decisions; facilitates the determination of relevant
costs; allows for the identification of actions geared toward the
reduction of overhead costs; provides a greater precision in
product costs; determines the costs of services/products; offers
support in the negotiation of contracts; provides support in the
increase in revenue, helping customers to understand the cost
reductions as consequence of the use of their products and
services; gives support for benchmarking; and determines the
remainder of shared services (BRASIL, 2006).
A study was recently conducted in Brazil aimed at supplying
subsidies for managers to identify the main cost guidelines and
possible gains in efficiency and effectiveness when adopting the
XpertMTB/RIF, using the ABC as a cost methodology to pinpoint
the advantage of being able to observe a significant quantity of
tests, thus making it possible to identify a standard cost and
conduct a detailed inventory of the cost items (Pinto et al., 2015).
In the Brazilian context, considering that the majority of
reference laboratories are structured to conduct bacilloscopies
and cultures to detect mycobacteria, it thus becomes necessary to
measure the real costs of both these technologies and the Detect
TB R© kit, the only national molecular method (BRASIL, 2010;
Michelon et al., 2011).
Therefore, the present study aimed to assess the mean cost and
ABC of the laboratory diagnosis of TB by means of conventional
techniques and the Detect TB R©LabTest molecular test kit in a
high-complexity general hospital from the public health system.
MATERIALS AND METHODS
Design and Study Site
This study’s cost analysis was performed by means of primary
data collected in the Research Laboratory in Mycobacteria (RLM)
of the Federal University of Minas Gerais (FUMG) School
of Medicine (SM), as well as in the Molecular Biology and
Public Health Laboratory (MBPH) of the FUMG School of
Pharmacy (SP), from January to December 2013. At RLM, TB
laboratory diagnoses are conducted on patients who receive
medical care at the hospital complex of the Clinical Hospital
(CH)/FUMG, a public and general university hospital that
conducts educational, research, and medical care activities.
CH/FUMG is a reference hospital in the municipal and state
health system concerning medical care provided to patients
with mid- and high-complexity pathologies, and consists of
one hospital unit and seven outpatient care centers (UFMG,
2015).
Study’s Cost Analysis
The costs of TB laboratory diagnoses (bacilloscopy and culture)
were evaluated based on two methodologies: by mean cost and by
activity. Mean Cost is calculated through the total cost divided by
the quantity produced over a determined period of time (BRASIL,
2006), which, in this study, considered the quantity of exams
conducted per month.
The ABC is calculated considering an activity as the
denominator for the calculation of the unit cost per activity,
rather than the real consumed quantity. The aim of this
procedure is to avoid fluctuations in the calculation of the
activity’s unit cost based on the variation of the real processed
quantity. The basic principle of this system is to make the largest
possible number of proportional and non-proportional costs
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more direct, through cost guidelines, as illustrated in Figure 1
(Khoury and Ancelevicz, 2000).
To calculate both costs (mean/ABC), this study verified the
values of all cost components of the assessed diagnostic methods,
such as: infrastructure, equipment, inputs, personal protective
equipment (PPE), human resources, and the maintenance of
biosafety laboratories (B3), according to the daily routine
at RLM/SM/FUMG in 2013. These data were collected by
consulting the purchasing, human resources, and maintenance
sectors after prior institutional authorization and study approval
by the Ethics Committee (CAAE -11821913.6.000.5257, CAAE –
0223.2412.7.1001.5149, DEPE/CH, protocol number 139/12).
Diagnostic Tests of Tuberculosis
Laboratory Routine
The RLM/SM/FUMG counts on two work flows to perform
a bacilloscopy: (1) direct bacilloscopy by ZN in samples from
emergency rooms and wards at the FUMG Clinical Hospital for
the release of exam results in up to four hours; (2) centrifuged
bacilloscopy to execute staining by means of the ZN method and
fluorescent (AU) of all of the other samples that arrive from the
Hospital Complex (out-patient care), including the samples in
which the direct bacilloscopy was performed.
The culture is performed in a Loweinstein-Jensen (LJ) solid
medium, using four tubes –two tubes without drugs and two
with p-Nitrobenzoic acid (PNB) and 2-thyophenecarboxylic acid
(TCH). The samples are decontaminated by the N-Acetyl L-
Cysteine (NALC) method (WHO, 2009). Monthly, the RLM
conducts an average of 100 bascilloscopies and 91 respiratory
sample cultures, such as sputum, bronchoalveolar lavage, and
endotracheal aspirates, as well as of extra-pulmonary samples,
such as cerebrospinal fluid, urine, biopsies, among others.
To calculate the costs of the Detect TB R© kit, only the
respiratory samples were considered, following both the
manufacturer’s recommendations (Labtest, 2012) and all
of the conditions established by RLM/SM/FUMG and
MBPH/SP/FUMG. The number of samples included in the
calculation for the Detect TB R© kit was only one per patient. All
costs were expressed in U$, using an exchange rate of US$ 1= R$
2,34 in 2013 according Brazilian Central Bank.
RESULTS
The Cost of Infrastructure
The results of the mean cost of the RLM/SM/FUMG
infrastructure are shown in Table 1; these items did not
influence the ABC of the verified methods. It can be observed
that security is the item that most influenced the mean cost.
The Cost of Diagnostic Tests of
Tuberculosis Laboratory Routine
The main items that influenced the mean costs and ABC of the
bacilloscopy, culture, and Detect TB R© kit are shown in Tables 2–4,
where one can observe an individual difference in the mean cost
of the equipment and a similarity of ABC for inputs. The unit
value of the disposable apron observed in Tables 2 and 3 is higher
than the other inputs, but did not affect the increase in mean cost
and ABC. The mean cost and ABC of the assessed technologies
are shown in Table 4; the cost components of each exam are
listed in Table 5. The Detect TB R© kit presented the highest
cost, followed by the culture and the centrifuged and direct
bacilloscopies. Among the cost components, in all of the assessed
methods, the inputs were what most influenced the increase in the
final value of each test followed by human resources, equipment
and permanent materials (Table 6).
TABLE 1 | Cost of Infrastructure of Research Laboratory in Mycobacteria
and Molecular Biology and Public Health Laboratory, FUMG.
Item Total monthly value Mean cost
Telephone U$ 227.35 U$ 0.45
Electricity U$ 291.02 U$ 0.58
Water U$ 400.85 U$ 0.80
Security U$ 3,571.52 U$ 7.14
Maintenance of B3 U$ 890.17 U$ 1.78
FIGURE 1 | Cost flow in the activity based costing systems. ∗Activity = performing one diagnostic test (bacilloscopy, culture, or Detect TB R©).
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TABLE 2 | Solid culture on Loweinsten–Jensen – main cost elements
Equipment Quantity of laboratories Unit value Mean cost Activity based cost
Refrigerated centrifuge 1 U$ 8,588.03 U$ 0.38 U$ 0.05
Biological Safety Cabinet 2 U$ 38,461.53 U$ 3.52 U$ 0.48
Refrigerator 2 U$ 512.82 – –
Freezer –20◦C. 1 U$ 769.23 – –
Bacteriological incubator 3 U$ 1,945.72 – U$ 0.03
Inputs Quantity per exam Unit value Mean cost Activity based cost
Polypropylene centrifuge tubes 1 U$ 0.51 U$ 0.55 U$ 0.51
Disposable apron (unit) 1∗ U$ 7.99 U$ 1.46 U$ 1.33
Tube with LJ medium 2 U$ 1.98 U$ 3.97 U$ 3.97
Tube with LJ medium with TCH 1 U$ 1.98 U$ 1.98 U$ 1.98
Tube with LJ-PNB medium 1 U$ 1.98 U$ 1.98 U$ 1.98
∗1 per day of work; LJ, Loweinstein–Jensen; TCH, 2-thyophenecarboxylic acid; PNB, p-Nitrobenzoic acid. Mean Cost is calculated through the total cost divided by the
quantity produced over a determined period of time (BRASIL, 2006). ABC is calculated considering an activity as the denominator for the calculation of the unit cost per
activity, rather than the real consumed quantity (Khoury and Ancelevicz, 2000). Exchange rate of US$ 1 = R$ 2,34 in 2013 according Brazilian Central Bank.
TABLE 3 | Cost of the main equipment and inputs for bacilloscopy.
Equipment Quantity of laboratories Unit value Mean cost Activity based cost
Test stand with running water 1 U$ 2,564.10 – U$ 0.01
Binocular microscope 1 U$ 1,227.35 – –
Led microscope 1 U$ 24,798.88 U$ 1.02 U$ 0.15
Refrigerated centrifuge 1 U$ 8,588.03 – U$ 0.05
Biological Safety Cabinet 2 U$ 38,461.53 U$ 3.20 U$ 0.48
Refrigerator 2 U$ 512.82 – –
Freezer –20◦C 1 U$ 769.23 – –
Inputs Quantity per exam Unit value Mean cost Activity based cost
Glass slides for microscopy 2 U$ 0.62 U$ 1.24 U$ 1.24
Polypropylene centrifuge tubes 1 U$ 0.51 U$ 0.51 U$ 0.51
Disposable apron (unit) 1∗ U$ 7.99 U$ 1.33 U$ 1.33
∗1 per day of work. Mean Cost is calculated through the total cost divided by the quantity produced over a determined period of time (BRASIL, 2006). ABC is calculated
considering an activity as the denominator for the calculation of the unit cost per activity, rather than the real consumed quantity (Khoury and Ancelevicz, 2000). Exchange
rate of US$ 1 = R$ 2,34 in 2013 according Brazilian Central Bank.
TABLE 4 | Main laboratory issued with impact on Detect TB R© test costs.
Equipment Quantity of laboratories Unit value Mean cost Activity based cost
Biological Safety Cabinet 2 U$ 38,461.53 U$ 8.01 U$ 4.45
MiliQ Water Purifier 2 U$ 7,692.30 U$ 1.60 U$ 0.88
Elisa Scanner 1 U$11,538.46 U$ 1.19 U$ 0.66
Hybridization Incubator 1 U$ 5,769.23 U$ 0.59 U$ 0.33
Thermocycler 1 U$10,256.41 U$ 1.06 U$ 0.59
Inputs Quantity per exam Unit value Mean cost Activity based cost
Detect TB R© KIT – U$ 2,289.74 U$ 31.80 U$ 31.80
Disposable apron (unit) 1∗ U$ 7.99 U$ 1.33 U$ 1.33
Nozzles with filter (26 per exam) 26 U$ 0.09 U$ 2.55 U$ 2.55
Microtubes 4 – – U$ 0.03
Disposable gloves 1 U$ 0.05 – U$ 0.11
∗1 per day of work. Mean Cost is calculated through the total cost divided by the quantity produced over a determined period of time (BRASIL, 2006). ABC is calculated
considering an activity as the denominator for the calculation of the unit cost per activity, rather than the real consumed quantity (Khoury and Ancelevicz, 2000). Exchange
rate of US$ 1 = R$ 2,34 in 2013 according Brazilian Central Bank.
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TABLE 5 | Mean and activity based cost from the Research Laboratory in Mycobacteria and Molecular Biology and Public Health Laboratory, FUMG.
Method Number of samples/month Mean cost Activity based cost
Centrifuged Bacilloscopy (ZN and AU) 100 U$ 10.06 U$ 5.61
Centrifuged Bacilloscopy (AU) 100 U$ 9.26 U$ 4.85
Centrifuged Bacilloscopy (ZN) 100 U$ 8.29 U$ 4.72
Direct Bacilloscopy (ZN) ∗ 100 U$ 7.42 U$ 4.15
Culture in LJ Solid Medium 91 U$ 27.38 U$ 16.50
Detect TB R© 40 U$ 115.74 U$ 73.46
∗Performed when request for bacilloscopy is urgent. ZN, Ziehl Neelsen, AU, Auramine O. ABC is calculated considering an activity as the denominator for the calculation
of the unit cost per activity, rather than the real consumed quantity (Khoury and Ancelevicz, 2000).
Exchange rate of US$ 1 = R$ 2,34 in 2013 according Brazilian Central Bank.
TABLE 6 | Cost components of activity based cost for each diagnostic test.
Inputs per test Equipment and permanent materials Human resources Total
Detect TB R© U$ 36.46 (55%) U$ 7.62 (11%) U$ 29.35 (34%) U$ 73.46
Solid Medium Culture U$ 11.40 (78%) U$ 0.62 (4%) U$ 3.19 (18%) U$ 16.50
Bacilloscopy by Flourescence (AU) U$ 3.08 (64%) U$ 0.50 (10%) U$ 1.26 (26%) U$ 4.85
Centrifuged Bacilloscopy (ZN) U$ 3.10 (66%) U$ 0.35 (8%) U$ 1.26 (26%) U$ 4.72
Direct Bacilloscopy (ZN) U$ 2.56 (62%) U$ 0.30 (7%) U$ 1.28 (31%) U$ 4.15
Centrifuged Bacilloscopy (ZN and AU) U$ 3.84 (69%) U$ 0.50 (9%) U$ 1.26 (22%) U$ 5.61
ZN, Ziehl Neelsen; AU, Auramine O. ABC is calculated considering an activity as the denominator for the calculation of the unit cost per activity, rather than the real
consumed quantity (Khoury and Ancelevicz, 2000).
Exchange rate of US$ 1 = R$ 2,34 in 2013 according Brazilian Central Bank.
DISCUSSION
The mean cost was higher than the ABC in the diagnosis of
pulmonary tuberculosis in the laboratory routine of a High-
Complexity Hospital in Brazil. The results of the mean cost and
ABC found in this study were of utmost importance for the re-
structuring of laboratory activities, since, faced with these results,
the routine of performing one slide stained with ZN and one with
AU in centrifuged bacilloscopy was changed to only one slide
stained with AU.
The impact that this result caused in the laboratory’s routine
showed the substantial advantage of having used the ABC as
the methodology, as well as the importance of conducting
cost studies based on data that has been duly computed and
not merely estimated based on other studies or the price of
the Unique Health System in Brazil. These data can serve
as a parameter for other public laboratories in Brazil that
perform the same TB diagnostic methods, in addition to
affirming that the correct count of the costs incurred in public
services is an important instrument for social control and
the assessment of the efficiency of services rendered (Martins,
2003).
The Detect TB R© kit was the method that presented the highest
costs. Nonetheless, it cannot be inferred whether or not the
implementation of this would in fact be more costly, given
that the sensitivity and specificity described by Michelon et al.
(2011), showed from 75 to 100% and 98 to 100%, respectively,
as compared to the bacilloscopy and culture, and presents the
advantage of a shorter waiting time for the release of the result as
compared to the culture. This fact reinforces the need for a cost
study on the effectiveness of this test in low-prevalence locations,
such as that carried out in the present work.
The values found for the Detect TB R© kit are similar to
other studies where molecular tests are assessed together with
conventional techniques (Shah et al., 2013). The value of the
Detect TB R© kit (U$73.46) found in our study is less than the value
of the Xpert MTB/RIF R© molecular method (U$ 503.05, value of
the cartridge) when not subsidized by the health system (BRASIL,
2013; FIND, 2013).
As regards, the bacilloscopy, it could be observed that there is
no need to perform two methods of staining, since the costs are
approximate and the AU technique is quick and sensitive, and
does not expose the technicians to toxic vapors released when
heating ZN (BRASIL, 2010). Despite the lower cost of staining
by ZN without centrifugation, this method is less sensitive than
centrifugation (WHO, 2009). The values of bacilloscopy found in
the present study differ from the values cited in a similar study
carried out in South Africa, where the ABC of the bacilloscopy
stained with AU presented the value of U$3.40 and with ZN
of U$2.25. Nevertheless, the values from the present study are
near those found in different scenarios in Brazil, where the
ABC of both staining methods was U$4.86 and for the mean
cost was U$ 6.05 (BRASIL, 2013; Shah et al., 2013). The costs
of bacilloscopy in Thailand by ZN and AU were US$1.16 and
US$1.03 respectively. In Zambia compared the values of the
culture by means of different techniques in liquid and solid media
found a variation between US$28 and $32. However, these studies
did not evaluate the mean cost and ABC. (Sohn et al., 2009a,b).
In the case of the culture, costs identified in the present study
(U$ 16.50) were similar to other studies carried out in Brazil and
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Africa, with a variation from U$ 12.35 to U$ 28.00 (Mueller et al.,
2008; Chihota et al., 2010; BRASIL, 2013).
The results of the ABC of the bacilloscopy and culture
found in this study and those reported in national literature
(BRASIL, 2013) are higher than the Brazilian Unified Health
System’s pay (U$ 1.79 for bacilloscopy and U$ 2.29 for
cultures), which alerts to the fact that these values do not
reflect the real cost. This divergence confirms the relevance
of the assessment of ABC, as the horizontal view of this
parameter made it possible to reach an analysis that was
not restricted to profit. This view is based on the planning,
performing, and aid in strategic decision-making, as well as
in the changes in processes, the elimination of waste, and
the drafting of estimates based on the executed activities,
thus increasing the efficiency of public services (Martins, 2003;
Alonso, 2009).
In some countries of Asia and America the health system is
private or public–private. In this context, the cost studies are
important to improve the ability of management and financing
of TB control programs (WHO, 2016).
The limitation of this study, rely on the fact that the
individual costs of the patients were not inferred, such
as: transport, outcome, among others, which are important
variables for future studies on cost effectiveness and the
implementation of an algorithm in laboratory diagnoses and
strategies for the TB control. In addition, this study was
carried out with local data from an NB3 laboratory geared
exclusively towards the diagnosis of TB and other mycobacteria
from high-complexity hospitals and from Molecular Biology
laboratories.
CONCLUSION
The calculation of the ABC should be used in making decisions
by administrators to be the best method of assessing the costs of
conventional techniques and molecular method for providing the
real value of the tests. So, it is need to calculate the ABC, and not
of the mean cost, in various scenarios before incorporating new
technologies in health institutions.
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